07:00 , Oct 6, 2016 |  BC Innovations  |  Product R&D

Local sensitivity

With a toolbox full of synthetic protein modules and a deal with Kite Pharma Inc. under its belt, Cell Design Labs Inc. is aiming to advance the next generation in cell-based therapies with a "smart"...
08:00 , Jan 29, 2015 |  BC Innovations  |  Strategy

PD-1 matchmaking

The rush to find combinations of PD-1 inhibitors and established cancer therapies marks the end of the beginning, rather than the beginning of the end, of the search for ways to extend use of checkpoint...
08:00 , Jan 30, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Psoriasis B and T lymphocyte attenuator (BTLA) Cell culture and mouse studies suggest agonizing BTLA could help treat psoriasis. In...
08:00 , Dec 9, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Transplantation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Transplantation Graft-versus-host disease (GvHD) B and T lymphocyte attenuator (BTLA) Studies in mice suggest that an agonist mAb targeting BTLA could help prevent GvHD. In a...
08:00 , Jan 31, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Other Adjuvant Adjuvants for stimulating host immune response and boosting vaccine efficacy In vitro and in vivo studies suggest that preventing B...